Volume 61, Issue 4, Pages (April 2002)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 67, Issue 2, Pages (February 2005)
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
Volume 79, Issue 1, Pages (January 2011)
Volume 53, Issue 4, Pages (April 1998)
Volume 67, Issue 3, Pages (March 2005)
Quantitative assessment of ischemic tissue damage in ovarian cortical tissue with or without antioxidant (ascorbic acid) treatment  S.Samuel Kim, M.D.,
Volume 67, Issue 1, Pages (January 2005)
Volume 61, Issue 2, (February 2002)
Volume 54, Issue 2, Pages (August 1998)
Volume 75, Issue 3, Pages (February 2009)
Volume 62, Issue 1, Pages (July 2002)
Volume 67, Issue 1, Pages (January 2005)
Volume 63, Issue 4, Pages (April 2003)
Volume 79, Issue 1, Pages (January 2011)
Volume 60, Issue 3, Pages (September 2001)
Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors  H.-S. Huang, J. Chen, C.-F. Chen,
Volume 70, Issue 7, Pages (October 2006)
Volume 69, Issue 1, Pages (January 2006)
Peritubular capillaritis in the renal allograft takes center stage
Volume 54, Issue 1, Pages (July 1998)
Volume 63, Issue 2, Pages (February 2003)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Trimetazidine reduces early and long-term effects of experimental renal warm ischemia: A dose effect study  Jerome Cau, MD, Frederic Favreau, PhD, Jean.
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 67, Issue 6, Pages (June 2005)
Volume 68, Issue 6, Pages (December 2005)
Volume 63, Issue 2, Pages (February 2003)
Volume 61, Issue 3, Pages (March 2002)
Volume 72, Issue 3, Pages (August 2007)
Volume 86, Issue 2, Pages (August 2014)
Volume 60, Issue 6, Pages (December 2001)
Volume 62, Issue 2, Pages (August 2002)
Volume 83, Issue 3, Pages (March 2013)
Volume 66, Issue 2, Pages (August 2004)
Volume 56, Issue 4, Pages (October 1999)
Role of CD8+ cells in the progression of murine adriamycin nephropathy
Volume 73, Issue 12, Pages (June 2008)
Volume 61, Issue 1, Pages (January 2002)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 68, Issue 2, Pages (August 2005)
Volume 56, Issue 2, Pages (August 1999)
Volume 63, Issue 5, Pages (May 2003)
Volume 61, Issue 4, Pages (April 2002)
Volume 60, Issue 6, Pages (December 2001)
Volume 67, Issue 2, Pages (February 2005)
Volume 76, Issue 7, Pages (October 2009)
Volume 72, Issue 2, Pages (July 2007)
Volume 75, Issue 5, Pages (March 2009)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 65, Issue 6, Pages (June 2004)
Volume 73, Issue 3, Pages (February 2008)
Volume 60, Issue 6, Pages (December 2001)
Volume 69, Issue 10, Pages (May 2006)
Citrate therapy for polycystic kidney disease in rats
Volume 71, Issue 6, Pages (March 2007)
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
H. Raffi, J.M. Bates, Z. Laszik, S. Kumar  Kidney International 
Volume 57, Issue 2, Pages (October 2000)
Volume 58, Issue 4, Pages (October 2000)
Volume 56, Issue 6, Pages (December 1999)
A functional immature model of chronic partial ureteral obstruction1
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes  Guorong Ma, Terri J. Allen, Mark E. Cooper,
Volume 59, Issue 6, Pages (June 2001)
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
Volume 61, Issue 6, Pages (June 2002)
Volume 70, Issue 9, Pages (November 2006)
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Volume 61, Issue 4, Pages 1383-1392 (April 2002) Protective effect of insulin on ischemic renal injury in diabetes mellitus  Jan Melin, Olof Hellberg, Erik Larsson, Lilian Zezina, Bengt C. Fellström  Kidney International  Volume 61, Issue 4, Pages 1383-1392 (April 2002) DOI: 10.1046/j.1523-1755.2002.00284.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Inulin clearance and urinary flow for each kidney in animals treated with long acting insulin. The different experimental groups are indicated by the following letters: A, untreated DM animals (N = 5); B, animals treated with insulin before I/R (N = 6); C, animals treated with insulin after I/R (N = 4). Median values in each group are indicated by horizontal lines. *P < 0.05 and **P < 0.01 between groups are indicated by brackets. Kidney International 2002 61, 1383-1392DOI: (10.1046/j.1523-1755.2002.00284.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Semiquantitative morphological evaluation of renal lesions for each kidney in animals treated with long acting insulin. The different experimental groups are indicated by the following letters: A, untreated DM animals (N = 5); B, animals treated with insulin before I/R (N = 6); C, animals treated with insulin after I/R (N = 4). Median values in each group are indicated by the horizontal lines. On the arbitrary scale used: 0 = no sign of inflammation, tubular dilation or fibrosis; 1 indicated mild changes; 2 = moderate damage; and 3 = severe lesions. *P < 0.05 and **P < 0.01 between groups as indicated by the brackets. Kidney International 2002 61, 1383-1392DOI: (10.1046/j.1523-1755.2002.00284.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Semiquantitative morphological evaluation of renal lesions for each kidney in the experiments with short-acting insulin showing inflammation, fibrosis or tubular dilation. The different experimental groups are indicated by the following letters: A, untreated DM animals (N = 3); B, animals treated with insulin before I/R (N = 9). The horizontal lines indicate median values in each group. On the arbitrary scale used: 0 = no sign of inflammation, tubular dilation or fibrosis; 1 = mild changes; 2 = moderate damage; and 3 = severe lesions. Kidney International 2002 61, 1383-1392DOI: (10.1046/j.1523-1755.2002.00284.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Photomicrographs from kidneys four weeks post-ischemia (picro-sirius and PAS staining). The kidneys from the animals that were not treated with insulin or received long acting insulin after the ischemic insult show severe damage. In the specimens stained with picro-sirius, fibrosis and tubular dilation can be seen. In the PAS-stained kidneys, inflammation, tubular atrophy and dilation are seen. Kidneys from animals treated with long acting insulin before ischemia show an almost normal morphology (original magnification ×50 for picro-sirius and ×200 for PAS). Kidney International 2002 61, 1383-1392DOI: (10.1046/j.1523-1755.2002.00284.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 Inulin clearance and urinary flow for each kidney in the experiments with short acting insulin. The different experimental groups are indicated by the following letters: A, untreated DM animals (N = 3); B, animals treated with insulin before I/R (N = 9). Median values in each group are indicated by the horizontal lines. *P < 0.05 DM between groups as indicated by brackets. Kidney International 2002 61, 1383-1392DOI: (10.1046/j.1523-1755.2002.00284.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 6 Number of TUNEL-positive nuclei per mm2 in the renal medulla and cortex six hours after ischemia. Treatment with long acting insulin started at least one week before I/R. Median values in each group are indicated by the horizontal lines. N = 6 in each group. *P < 0.05 between groups as indicated by brackets. Kidney International 2002 61, 1383-1392DOI: (10.1046/j.1523-1755.2002.00284.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 7 Detection of cell death by TUNEL in the renal medulla six hours after ischemia. (A) Kidney from an untreated DM animal. A large number of positive nuclei defined by fluorescence are seen in the tubuli and some in the interstitium of the outer medulla in the kidney from the untreated DM animal. (B) Kidney from a DM animal treated with long acting insulin one week before ischemia. No apoptotic cells are detected in this picture. (Original magnification ×200). Kidney International 2002 61, 1383-1392DOI: (10.1046/j.1523-1755.2002.00284.x) Copyright © 2002 International Society of Nephrology Terms and Conditions